Literature DB >> 27303085

Macro and Micro Level Usage of Outcomes Research in Pharmacy Practices.

Rafia S Rasu.   

Abstract

Year:  2016        PMID： 27303085      PMCID： PMC4896340          DOI： 10.1310/hpj5105-351

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


× No keyword cloud information.
  7 in total

1.  Anticonvulsant use after formulary status change for brand-name second-generation anticonvulsants.

Authors:  Hemal Patel; Diana C Toe; Shawn Burke; Rafia S Rasu
Journal:  Am J Manag Care       Date:  2010-08       Impact factor: 2.229

2.  Key principles for the improved conduct of health technology assessments for resource allocation decisions.

Authors:  Michael F Drummond; J Sanford Schwartz; Bengt Jönsson; Bryan R Luce; Peter J Neumann; Uwe Siebert; Sean D Sullivan
Journal:  Int J Technol Assess Health Care       Date:  2008       Impact factor: 2.188

3.  Communicating and promoting comparative-effectiveness research findings.

Authors:  Peter J Neumann
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

Review 4.  Comparative effectiveness research: Relevance and applications to pharmacy.

Authors:  Glen T Schumock; A Simon Pickard
Journal:  Am J Health Syst Pharm       Date:  2009-07-15       Impact factor: 2.637

5.  Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I.

Authors:  Marc L Berger; Muhammad Mamdani; David Atkins; Michael L Johnson
Journal:  Value Health       Date:  2009-09-29       Impact factor: 5.725

6.  Design, implementation, and first-year outcomes of a value-based drug formulary.

Authors:  Sean D Sullivan; Kai Yeung; Carol Vogeler; Scott D Ramsey; Edward Wong; Chad O Murphy; Dan Danielson; David L Veenstra; Louis P Garrison; Wylie Burke; John B Watkins
Journal:  J Manag Care Spec Pharm       Date:  2015-04

7.  An updated method for risk adjustment in outcomes research.

Authors:  Suhail A R Doi; Jan J Barendregt; Chalapati Rao
Journal:  Value Health       Date:  2014-06-23       Impact factor: 5.725
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.